JP Morgan Chase’s Alerian MLP Index ETNs due January 28 2044 AMJB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$65.7M Sell
1,907,023
-254,000
-12% -$8.88M ﹤0.01% 1288
2026
Q1
$75.8M Sell
2,161,023
-184,000
-8% -$6.13M ﹤0.01% 1127
2025
Q4
$70.1M Buy
2,345,023
+335,000
+17% +$9.95M ﹤0.01% 1143
2025
Q3
$59.3M Buy
2,010,023
+130,000
+7% +$3.94M ﹤0.01% 1302
2025
Q2
$56.9M Sell
1,880,023
-910,000
-33% -$27.4M ﹤0.01% 1254
2025
Q1
$90.6M Sell
2,790,023
-2,306,977
-45% -$73.9M 0.01% 978
2024
Q4
$150M Sell
5,097,000
-348,000
-6% -$10.2M 0.01% 763
2024
Q3
$155M Sell
5,445,000
-140,000
-3% -$4.01M 0.01% 779
2024
Q2
$162M Buy
5,585,000
+1,725,000
+45% +$48.6M 0.01% 730
2024
Q1
$110M Buy
+3,860,000
New +$106M 0.01% 897

Other funds holding AMJB

JP Morgan Chase's AMJB Position: Q2 2026 in Review

JP Morgan Chase reduced its Alerian MLP Index ETNs due January 28 2044 (AMJB) stake by 12% in Q2 2026, selling an estimated $8.88M and leaving 1,907,023 shares worth $65.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1288.

JP Morgan Chase first reported a position in AMJB in Q1 2024 and has held it in 10 quarters since. The position peaked at $162M in Q2 2024. 72 funds tracked by Wall St. Rank hold AMJB as of Q2 2026.

  • JP Morgan Chase held 1,907,023 shares of Alerian MLP Index ETNs due January 28 2044 worth $65.7M as of Q2 2026.
  • JP Morgan Chase sold 254,000 Alerian MLP Index ETNs due January 28 2044 shares in Q2 2026, an estimated $8.88M.
  • Alerian MLP Index ETNs due January 28 2044 made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #1288 holding.
  • JP Morgan Chase first reported a position in Alerian MLP Index ETNs due January 28 2044 in Q1 2024 and has held it in 10 quarters since.
  • JP Morgan Chase's Alerian MLP Index ETNs due January 28 2044 position peaked at $162M in Q2 2024.
  • 72 funds tracked by Wall St. Rank held Alerian MLP Index ETNs due January 28 2044 as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.